ÂÜÀòÂÒÂ×

Thomas Whelan is currently the Director of Accounting at Zenas BioPharma, a position held since June 2023. Prior to this role, Thomas served as Associate Director and Controller, as well as Assistant Controller at Repertoire Immune Medicines from July 2021 to June 2023. Thomas's experience also includes serving as Accounting Manager at Repligen Corporation from March 2020 to July 2021, and as Accounting Lead and Senior Accountant at Alnylam Pharmaceuticals from July 2017 to March 2020. Earlier in the career, Thomas worked at Ernst & Young in the FSO Assurance - Asset Management division from August 2012 to July 2017. Thomas holds a Master of Science in Accounting and a Bachelor of Science in Corporate Finance & Accounting, both from Bentley University.